PUMA BIOTECHNOLOGY INC (PBYI)
US74587V1070 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 21.59M | 0.00 | -29.13M | -60.00M | -75.60M | |||
| Depreciation Amortization | 11.52M | 8.92M | 10.60M | 10.03M | 8.08M | |||
| Change In Working Capital | -17.85M | -43.58M | -600.00K | 13.16M | 23.28M | |||
| Interest Paid | 11.63M | 10.32M | 10.34M | 9.70M | 11.74M | |||
| Taxes Paid | 737.00K | 380.00K | 320.00K | 210.00K | N/A | |||
| Other non cash items | 11.75M | 18.83M | 39.78M | 37.58M | 66.61M | |||
| OPERATING CASH FLOW | 27.01M | -15.83M | 20.65M | 770.00K | 22.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -12.64M | -7.00M | 0.00 | -20.05M | -310.00K | |||
| Other Investing Activity | -6.49M | 14.10M | -10.88M | 43.45M | 5.47M | |||
| INVESTING CASH FLOW | -19.13M | 7.10M | -10.88M | 23.40M | 5.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 0.00 | -1.50M | 0.00 | -55.00M | |||
| Stock Issued/Repurchased | 0.00 | 12.22M | 0.00 | 70.00K | 1.35M | |||
| Other Financing Activity | 0.00 | 0.00 | -30.43M | 0.00 | -13.42M | |||
| FINANCING CASH FLOW | 0.00 | 12.22M | -31.93M | 70.00K | -67.07M | |||
| CHANGE IN CASH | 7.88M | 3.49M | -22.16M | 24.24M | -39.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 27.01M | -15.83M | 20.65M | 770.00K | 22.38M | |||
| Capital Expenditure | -12.64M | -7.00M | 0.00 | -20.05M | -310.00K | |||
| FREE CASH FLOW | 14.37M | -22.83M | 20.65M | -19.28M | 22.07M | |||
All data in USD